Company

mAbsolve

Biotechnology Research Oxford, Oxfordshire, United Kingdom 6 employees

Employees: 6
Contacts: 4
Emails: 4
Phones: 2

mabsolve.com LinkedIn

mAbsolve Overview

Headquarters: Oxford, Oxfordshire, United Kingdom
Website: mabsolve.com
Industry: Biotechnology Research
Employees: 6
Founded: 2019
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

monoclonal antibodies Fc fusion proteins Fc receptors antibody engineering cytokine release immunogenicity complement biotechnology licensing

About mAbsolve

Our founders were pioneers of monoclonal antibody therapy, bringing to the clinic the first humanised antibody, the first made in CHO cells, the first bispecific and the first aglycosylated antibody. Now we have developed a new Fc variant which is more comprehensively silenced than previous antibodies. It is able to reduce unwanted inflammatory responses from the next generation of antibody-based drugs. We are building partnerships with Universities, Biotech and Pharma companies to make this new technology widely available.

mAbsolve Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

mAbsolve Org Chart

Sample employees and titles

Name	Title	Location	Contact
Mike Clark	Immunologist - Antibody Engineering Consultant - Biotech Investor	Settle, England, United Kingdom	Email
Ian Wilkinson	Biotech Founder & Advisor - Innovating Protein Reagents	Durham, England, United Kingdom	Email Phone
Michael Fiebig	Chief Scientific Officer at Absolute Antibody	United Kingdom	Email Phone
Tim Bernard	CEO @ Pivotal Scientific - Founder, Investor	Greater Oxford Area, United Kingdom	Email